EQS-News: Sartorius releases Annual Report for 2024

Göttingen, Germany | February 17, 2025 Sartorius releases Annual Report for 2024 The life science group Sartorius today released its Annual Report for 2024. The document is available at the following link: ir-reports.sartorius.com/en/ag/fy-2024/   Financial calendarMarch 27, 2025         Annual Shareholders’ Meeting April 16, 2025             Publication of the first quarter results January to March 2025 July 22, 2025              Publication of the half-year results January to June 2025October 16, 2025    Publication of the nine-month results January to September 2025  A profile of Sartorius Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and sustainably. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. Around 13,500 employees are working for customers around the globe. Visit our Newsroom and follow Sartorius on LinkedIn.  ContactLeona MalornyHead of External Communications+49 551 308 4067leona.malorny@sartorius.com